Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Cancers|February 13, 2026
Perioperative Immune-Checkpoint Inhibition in Renal Cell Carcinoma: Lessons Learned and Future DirectionsAdam Adika, Matthew ZibelmanAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer ContraindicationsJustine V Cohen, Adam Adika, Matthew Zibelman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 17, 2019
Full Spectrum: Efficacy and Toxicity of Immunotherapy in Metastatic MelanomaMatthew Zibelman, Anthony OlszanskiAmerican Journal of Clinical Oncology|March 12, 2016
Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and NeckMatthew Zibelman, Ranee MehraFuture Oncology (London, England)|July 13, 2016
Systemic therapy for bladder cancer finally comes into a new ageMatthew Zibelman, Elizabeth R PlimackJournal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Integrating Immunotherapy Into the Management of Renal Cell CarcinomaMatthew Zibelman, Elizabeth R PlimackJournal of Personalized Medicine|November 18, 2020
Biomarker Development for Metastatic Renal Cell Carcinoma: Omics, Antigens, T-cells, and BeyondBenjamin Miron, David Xu, Matthew ZibelmanFuture Oncology (London, England)|June 1, 2018
Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancerFern Anari, Chethan Ramamurthy, Matthew ZibelmanCancers|August 7, 2021
Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New OpportunitiesKevin Zarrabi, Emily Walzer, Matthew ZibelmanJournal for Immunotherapy of Cancer|February 18, 2016
Autoimmune inner ear disease in a melanoma patient treated with pembrolizumabMatthew Zibelman, Natasha Pollak, Anthony J OlszanskiPageof 6